Date: Location: Cost:
November 7 - 8, 2017 Apella at Alexandria Center
450 E. 29 Street
New York, NY 10016
(212) 706-4100
Location >

Starting at $1950


Dress Code:
Business Attire


NY/NJ CEO - November 7, 2017 - DRAFT

Time Agenda
7:30-8:30 am

Registration & Networking Breakfast

8:30-8:45 am

Welcome and Opening Remarks

8:45-9:15 am

Industry Outlook in Election Season
Ron Cohen, President & CEO, Acorda; Mani Mohindru, Chief Strategy Officer, Curis; Francois Nader, Chairman, Acceleron Pharma; Deepa Pakianathan, Managing Member, Delphi Ventures

9:15-9:45 am

State of the Markets: Biotech and Pharma
Robert Forrester, CEO, Verastem; Jay Galeota, President & COO, G&W Labs; Bob Oliver, President & CEO, Otsuka; Ron Squarer, CEO, Array BioPharma
Moderator: Simos SimeonidisManaging Director Biotechnology Equity Research, RBC Capital

9:45-10:05 am

Moderated Keynote
Bob Greifeld

10:05-10:35 am

Networking Break

10:35-11:05 am

Financing Innovation: What to Look For
Andrew Curtis, Head, Corporate Strategy & BD, Affimed; Rekha Hemrajani, COO, FLX Bio; Leen Kawas, President & CEO, M3 Biotechnology; Jak Knowles, Managing Director, CureDuchenne; Julia Owens, President & CEO, Millendo Therapeutics
Moderator: Paris Panayiotopoulos, President & CEO, ARIAD

11:05-11:35 am

Non-Dilutive Financing and Alternative Financing Methods
Harvey Berger, former CEO, Ariad; Adam GridleyPresident & CEO, Histogenics; Matthew Kane, CEO, Precision BioSciences; Pedro Lichtinger, former CEO, Asterias Biotherapeutics
Moderator: Janelle Anderson, Managing Director, CTI Life Sciences

11:35-12:05 pm

Immune-Oncology Trends and Predictions
Ramon Mohanlal, CMO, BeyondSpring Pharmaceuticals; Matt Roden, Head, Strategic Corporate Development, Bristol-Myers Squibb; Robert Stein, President, R&D, Agenus; Daniel Teper, CEO, IMMUNE Pharmaceuticals; Maurice Zauderer, President & CEO, Vaccinex
Moderator: Al Beardsley, COO, Galera Therapeutics

12:05-1:00 pm

Networking Lunch

1:00-1:30 pm

Big Pharma and Biotech Perspectives: Takeaways from the Past Year
Scott Brun
, VP, Clinical Development, Global Pharmaceutical R&D, AbbVie; Emmanuel Caeymaex, EVP, Head, Immunology Patient Value Unit, UCB; Rivka Kreitman, SVP, Head, Global Search & Evaluation, Teva; Philippe Lopes-FernandesSVP, Global Head of BD & Alliance Management, EMD Serono
Moderator: Brian McVeigh, VP WWBD, GlaxoSmithKline

1:30-2:00 pm

Defining the Value of Drugs: A Roadmap for Success
Luigi CostaCEO, Nordic Nanovector; Cedric Francois, President & CEO, Apellis Pharmaceuticals; Ramesh Kumar, President & CEO, Onconova; Niven Narain, Co-Founder, President & CEO, Berg; Vivek Ramaswamy, CEO, Axovant; Sam Waksal, Founder, Kadmon

2:00-2:20 pm

Moderated Keynote
Frank Yu
, Founder & CEO, Ally Bridge Group
Moderator: Christoph Westphal, Co-Founder & Partner, Longwood Fund

2:20-2:40 pm

Fireside Chat
Ron Cohen, President & CEO, Acorda; Mark Pruzanski, CEO, Intercept Pharmaceuticals
Moderator: Christoph Westphal, Co-Founder & Partner, Longwood Fund

2:40-3:10 pm

Networking Break

3:10-3:40 pm

Accessing Innovation in Drug Discovery: Where and How?
Zandy ForbesPresident & CEO, MeiraGtx; Julie Krop, CMO & SVP Clinical Development & Regulatory Affairs, AMAG Pharmaceuticals; Jonathan Lewis, CEO, Samus Therapeutics; Nancy Thornberry, CEO, Kallyope
Moderator: John HaurumCEO, F-star Biotechnology

3:40-4:10 pm

IPOs, PIPES, Form 10s and Secondaries: Exits and Alternative Strategies
Martin Driscoll, CEO, Spring Bank Pharmaceuticals; Sapna Srivastava, Chief Financial & Strategy Officer, Intellia Therapeutics; Mary Thistle, CBO, Dimension Therapeutics; Stephen Yoder, President & CEO, Pieris Pharmaceuticals

4:10-4:30 pm

Moderated Keynote
Mikael Dolsten, President, Worldwide R&D, Pfizer

4:30-6:00 pm

Cocktails & Hors d’oeuvres

NY/NJ CEO - November 8, 2017 - DRAFT

Time Agenda
7:30-8:30 am

Registration & Networking Breakfast

8:30-8:45 am

Welcome and Opening Remarks

8:45-9:15 am

Healthcare Market Dynamics: Predictions for 2017
Arthur Hiller, CEO, Antyllus; Martin Lehr, CEO, Context Therapeutics; Hamza Suria, President & CEO, AnaptysBio

9:15-9:45 am

Therapeutic Market Focus: Microbiome
Karim Dabbagh, CSO, Second Genome; Xavier Duportet, CEO & Chairman, Eligo Bioscience; Bernat OlleCEO, Vedanta Biosciences; Todd Patrick, President & CEO, C3J Therapeutics
Moderator: Lee JonesPresident & CEO, Rebiotix

9:45-10:15 am

The Cost of Developing a Drug: Alternative Financing Strategies
Richard Daly, President & CEO, Neuralstem; Mark Schwartz, President & CEO, Galena Biopharma
Moderator: Joseph PaynePresident & CEO, Arcturus Therapeutics

10:15-10:45 am

Networking Break

10:45-11:15 am

Rare Disease Economics: Impact on the Industry
Dipal Doshi, CBO, Amicus; Ken Moch, Managing Partner, Salutramed; Cynthia Schwalm, EVP, Commercial Operations, North America, Ipsen; David Soergel, CMO, Trevena
Moderator: Shalabh GuptaFounder & CEO, Globavir

11:15-11:45 pm

Academia and Biotech/Pharma Collaborations
Morgan Conn, Vice President, Business Development, PTC Therapeutics; Anna Maroney, VP, Head, Alliance Management, AbbVie; Helen Montag, Senior Director, Johns Hopkins Technology Ventures
Moderator: Alan EzekowitzPresident & CEO, Abide Therapeutics

11:45-12:15 pm

Venture Financing: Maintaining Momentum
Bernard Davitian, VP & Managing Director, Sanofi-Genzyme BioVentures; Jan-Anders KarlssonCEO, Verona Pharma; Nick Naclerio, Founder & Managing Director, Illumina Ventures; Carlo Rizzuto, Partner, Versant Ventures
Moderator: Greg Mayes, EVP & COO, Advaxis

12:15-1:00 pm

Networking Lunch

1:00-1:20 pm

Fireside Chat
David Epstein, former CEO, Novartis Pharmaceuticals
Moderator: Christoph Westphal, Co-Founder & Partner, Longwood Fund

1:20-1:50 pm

Accelerating Development by Leveraging Emerging Markets
Ron Cooper, President & CEO, Albireo Pharma; Sandeep Duttagupta, VP & Principal, Emerging Markets, CBPartners; Ryuji Hiramatsu, Head, Global Innovation, Foundation for Biomedical Research; Rachel Humphrey, SVP & CMO, CytomX; Thomas Lonngren, former Executive Director, EMA
Moderator: Glenn Kazo, President, Prolong Pharmaceuticals

1:50-2:20 pm

Innovative Deals and Partnerships
Nessan Bermingham, CEO, Intellia Therapeutics; Philippe Lopes-Fernandes, SVP, Global Head of BD & Alliance Management, EMD Serono; Bob Silverman, Head, Externalized Drug Discovery Partnering, Roche; Susan Solomon, CEO & Co-Founder, NYSCF

2:20-2:50 pm

Networking Break

2:50-3:20 pm

Biotech Valuations in 2016
Leland Gershell, CFO, Capricor Therapeutics; Anna Kazanchyan, Chairman & CEO, Saghmos Therapeutics; Brian LeuthnerPresident & CEO, Edge Therapeutics
Moderator: Harlan Waksal, President & CEO, Kadmon

3:20-3:50 pm

Public and Private Markets
Stephen Parker, Non-Executive Chairman, Silence Therapeutics; Mark SimonPartner, Torreya Partners; Yaron Werber, Chief Business & Financial Officer, Ovid Therapeutics

3:50-4:10 pm

Fireside Chat
George Yancopoulos, President & CSO, Regeneron

4:10-4:30 pm

Presentation of NY/NJ CEO Lifetime Achievement Award
Presented by: Francois Nader, 2016 Honoree; Ron Cohen, 2013 Honoree; George Yancopoulos, 2012 Honoree

4:30-5:30 pm

Cocktails & Hors d'oeuvres

Premier Sponsors: (see all sponsors)